Chair: Joseph Bielitzki, University of Central Florida
China Highlights, Joseph Bielitzki, University of Central Florida
10.00 Why did the Chinese and Australians lead the world in producing vaccine for H1N1, being months ahead of North America and Europe?
1.45 Executive Overview , Joseph Bielitzki
[photo: Joseph Bielitzki]
Joseph Bielitzki,(Panel Chair) , MS, DVM
has a diverse background in science.
early experience is in the infectious agents affecting non human primates, especially the enteric diseases.
He worked for 18 years in the National Primate Center System at both the University of Washington and the Yerkes Center of Emory University supporting research across a wide range of biomedicine.
In 1996, he became the Chief Veterinary Officer for NASA, where his efforts focused on coordinating the agency wide animal care and use program, compliance issues, hardware design and training.
served on the working group for safety issues surrounding sample return missions from Martian environments.
In 2000, he served as a government advisor on a task force for a Defense Science Board looking at defense against biological warfare.
In 2001, Joe accepted a position as a Program Manager in the Defense Sciences Office at DARPA.
At DARPA, he managed an extensive portfolio of life science research including, Long Term Storage of Blood Products, Peak Soldier Performance, Rapid Vaccine Assessment, Surviving Blood Loss, Restorative Injury Repair, Biofilms for Defense, Pathogen Countermeasures and Accelerated Anthrax Therapeutics.
During this period, Joe
interacted with a variety of federal agencies in the area of biological warfare defense.
After DARPA, he relocated to Orlando, where he currently supports the Office of Research and Commercialization at the University of Central Florida and has an appointment in the College of Bimolecular Sciences and Microbiology.
also consults in the area of science and technology development for academia, industry and the government.
Immunology, microbiology, pathogen evolution and protective mechanisms of immunity remain a primary interest for him.
is recognized for his
expertise in the ethical issues surrounding the use of animals in research.